ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.17
-0.05 (-4.10%)
As of Feb 8, 2:35 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +212.0% upside
Low Target $2.40
Average Target $3.65
High Target $4.80
Current Price $1.17
Current
$1.17
Target
$3.65
$2.40 $3.65 avg $4.80
Scenario Analysis
Bear Case
$2.40
105.1%
Low target
Base Case
$3.65
+212.0%
Avg target
Bull Case
$4.80
+310.3%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$3.39
-65.5% from high
52-Week Low
$1.68
+-30.4% from low
Target vs 52W High
$3.65
+7.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%